Position in REPL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$907,540
New position
Shares Held
81,982
first reported quarter
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 199 holders
Holding Since
Jun 2026
1 quarter on record
Position in Biotechnology
Healthcare · as of Jun 30, 2026IEQ CAPITAL, LLC holds $235,945,693 across 100 Biotechnology names. REPL ranks #34 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
424,682 | $48,141,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,105 | $29,995,391 | |
| 3 | EXEL |
Exelixis, Inc.
|
451,768 | $24,580,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
37,339 | $18,547,400 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
197,988 | $11,328,873 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
58,834 | $11,018,430 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
92,394 | $8,033,658 | |
| 8 | BHVN |
Biohaven Ltd.
|
475,865 | $7,080,871 |
All Filings in REPL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $907,540 | 81,982 | Shares | Other | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||